US 10471061
Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders
granted A61KA61K31/506A61K31/517
Quick answer
US patent 10471061 (Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/506, A61K31/517, A61K31/527, A61P